Viemed Healthcare (VMD) Competitors

The Pennant Group (NASDAQ:PNTG) and Viemed Healthcare (NASDAQ:VMD) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, media sentiment, institutional ownership, community ranking and valuation.

Does the media refer more to PNTG or VMD?

In the previous week, The Pennant Group had 10 more articles in the media than Viemed Healthcare. MarketBeat recorded 11 mentions for The Pennant Group and 1 mentions for Viemed Healthcare. The Pennant Group's average media sentiment score of 1.24 beat Viemed Healthcare's score of 1.11 indicating that The Pennant Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
The Pennant Group	7 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Viemed Healthcare	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has preferable earnings & valuation, PNTG or VMD?

The Pennant Group has higher revenue and earnings than Viemed Healthcare. Viemed Healthcare is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
The Pennant Group	$748.17M	1.32	$13.38M	$0.76	37.67
Viemed Healthcare	$232.79M	1.13	$10.24M	$0.30	22.23

Do institutionals and insiders believe in PNTG or VMD?

85.9% of The Pennant Group shares are held by institutional investors. Comparatively, 74.2% of Viemed Healthcare shares are held by institutional investors. 5.8% of The Pennant Group shares are held by company insiders. Comparatively, 20.0% of Viemed Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Does the MarketBeat Community prefer PNTG or VMD?

The Pennant Group received 39 more outperform votes than Viemed Healthcare when rated by MarketBeat users. Likewise, 46.15% of users gave The Pennant Group an outperform vote while only 42.86% of users gave Viemed Healthcare an outperform vote.

Company	Underperform	Outperform
The Pennant Group	Outperform Votes 42 46.15%	Underperform Votes 49 53.85%
Viemed Healthcare	Outperform Votes 3 42.86%	Underperform Votes 4 57.14%

Do analysts rate PNTG or VMD?

The Pennant Group presently has a consensus price target of $35.60, indicating a potential upside of 24.35%. Given The Pennant Group's stronger consensus rating and higher probable upside, analysts clearly believe The Pennant Group is more favorable than Viemed Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
The Pennant Group	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60
Viemed Healthcare	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has more volatility and risk, PNTG or VMD?

The Pennant Group has a beta of 1.56, meaning that its share price is 56% more volatile than the S&P 500. Comparatively, Viemed Healthcare has a beta of 1.49, meaning that its share price is 49% more volatile than the S&P 500.

Is PNTG or VMD more profitable?

Viemed Healthcare has a net margin of 4.87% compared to The Pennant Group's net margin of 3.24%. The Pennant Group's return on equity of 13.47% beat Viemed Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
The Pennant Group	3.24%	13.47%	3.81%
Viemed Healthcare	4.87%	8.72%	6.48%

Summary

The Pennant Group beats Viemed Healthcare on 15 of the 18 factors compared between the two stocks.